J Magn Reson Imaging. 2022 Oct 31. doi: 10.1002/jmri.28509
A. Lavielle, F. Boux, J. Deborne, et al.
Scientific Publications – Major
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)
Radiother Oncol., 2021, 160, 159-165.
C. Verry, S. Dufort, J. Villa, et al.
PET-MRI nanoparticles imaging of blood-brain barrier damage and modulation after stroke reperfusion
Brain Communications, 2020, 2, fcaa193.
J. Debatisse, O. Fakur Eker, O. Wateau, et al.
Anti-MUC1- C Antibody – conjugated nanoparticles potentiate the efficacy of fractionated radiation therapy
Int. J. Radiat. Oncol. Biol. Phys., 2020, 20, 6223.
A. Detappe, C. Mathieu, C. Jin, et al.
Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective
Science Advances, 2020, 6, eaay5279.
C. Verry, S. Dufort, B. Lemasson, et al.
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX® nanoparticles
Theranostics, 2020, 10, 1319-1331.
G. Bort, F. Lux, S. Dufort, et al.
Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol
BMJ Open, 2019, 9, e023591.
C. Verry, L. Sancey, S. Dufort, et al.
One-pot direct synthesis for multifunctional hybrid silica nanoparticles
J. Mat. Chem. B, 2018, 6, 4821-4834.
V. –L. Tran, V. Thakare, F. Rossetti, et al.
AGuIX® from bench to bedside – Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
Br. J. Radiology, 2018, 91, 20180365.
F. Lux, V.-L. Tran, E. Thomas, et al.
Ultrasmall silica-based bismuth gadolinium nanoparticle for dual MR-CT guided radiation therapy
Nano Lett., 2017, 17, 1733-1740.
A. Detappe, E. Thomas, M. W. Tibbit, et al.
Synthesis and characterization of 89Zr-labeled ultrasmall nanoparticles
Mol. Pharm., 2016, 13, 2596-2601.
C. Truillet, E. Thomas, F. Lux, et al.
Safety evaluation and imaging properties of gadolinium based nanoparticles in nonhuman primates
Scientific Report, 2016, 6, 35053.
S. Kotb, J. Piraquive, F. Lamberton, et al.
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy
J. Control. Release, 2016, 238, 103-113.
A. Detappe, S. Kunjachan, L. Sancey, et al.
Gadolinium-based nanoparticles and radiation therapy for multiple brain melanoma metastases : Proof of concept before phase I trial
Theranostics, 2016, 6, 418-427.
S. Kotb, A. Detappe, F. Lux, et al.
The high radiosensitizing efficiency of a trace of gadolinium-based nanoparticles in the tumor
Sci. Rep., 2016, 6, 29678.
S. Dufort, G. Le Duc, M. Salomé, et al.
MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection
Nanomedicine, 2016, 11, 2405-2417.
C. Verry, S. Dufort, E. L. Barbier, et al.
Long-Term in vivo clearance of Gadolinium-Based AGuIX (Activation and Guiding of Irradiation by X-Ray) Nanoparticles and their Biocompatibility after Systemic Injection
ACS Nano, 2015, 9, 2477-2488.
L. Sancey, S. Kotb, C. Truillet, et al.
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
Br. J. Radiology, 2014, 87, 20140134.
L. Sancey, F. Lux, S. Kotb, et al.
A top-down synthesis route to ultrasmall multifunctionnal Gd-based nanoparticles for theranostic applications
Chem. Eur. J., 2013, 19, 6122-6136.
A. Mignot, C. Truillet, F. Lux, et al.
Ultrasmall Rigid Platforms as multimodal probes for medical applications
Angew. Chem. Int. Ed., 2011, 51, 12299-13303.
F. Lux, A. Mignot, P. Mowat, et al.